Lee SD, Vermeire S, Ungaro R, Vadhariya A, et al. Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 study. Am J Gastroenterol 2025 Mar 13. doi: 10.14309/ajg.0000000000003410.
PMID: 40079470